Skip to main content

Want a detailed portfolio tracker?

AEON
AMEX
$0.29

AEON Biopharma Inc - Class A (AEON)

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. The company is headquartered in Newport Beach, California.
Website: https://www.aeonbiopharma.com
Sector:
Healthcare
Industry:
Biotechnology
Target: $6.70 (+2246.76%)

Market Cap

$7.31M

Beta (5Y)

0.35

Price Chart

Valuation
Market Cap$7.31M
Forward P/E1.16
P/S97.16
Profitability
EBITDA-$18M
EPS-$4.50
Growth & Risk
Beta (5Y)0.35
Sharpe Ratio-0.50